Skip to main content
OpenTrials
Completed

NCT Number: NCT05119153

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Schaub Hall, Campus Box 7624

Raleigh, North Carolina, 27695, United States

About this study

This is a single-blinded, randomized partial block design conducted over 6 weeks in two parts.

In part 1 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a beverage containing 50 g of glucose.

In part 2 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a standardized breakfast (corn flakes cereal + skim milk) containing 50 g of glucose.

In each part, fasting and postprandial glucose profiles were determined.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

Exclusion criteria

  • Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.
  • Weight less than 110 pounds (55 kg)
  • Pre-existing health conditions, such as:
  • High cholesterol
  • Hypertension
  • Cardiovascular disease
  • Gastrointestinal motility disorders
  • Hypo- or hyperthyroidism
  • Anemia
  • Renal disease
  • Liver disease, including hepatitis B or C, cholestasis, cirrhotic liver disease, or non-alcoholic fatty liver disease
  • Chronic or acute pancreatitis
  • Diabetes type 1 or 2
  • Insulin resistance
  • Polycystic ovary syndrome
  • Food allergies or intolerances to coffee/caffeine/dairy/corn-based cereals.
  • Currently taking prescription medication
  • Current smoker
  • Consumes more than 3 alcoholic beverages per day
  • Pregnant or breastfeeding
  • Not willing to take their own blood samples with finger sticks

Treatment and study plan

Placebo Comparator

Dietary Supplement

Placebo designed to mimic coffee color.

Light Roasted Coffee

Dietary Supplement

12 oz light roast coffee

Medium Roasted Coffee

Dietary Supplement

12 oz medium roast coffee

Dark Roasted Coffee

Dietary Supplement

12 oz dark roast coffee

Primary outcomes

  1. Changes in Blood Glucose

    Time frame: 6 weeks

    Each week, fasted baseline and postprandial measurements taken out to 240 minutes

Secondary outcomes

  1. Changes in Glucose Area Under the Curve

    Time frame: 6 weeks

    Used glucose changes over 240 minutes to construct area under the curve

Sponsors and collaborators

Lead sponsor

North Carolina State University

Other

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2021
First posted
Nov 12, 2021
Registry last updated
Nov 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.